Genetically altered cancer epigenome

Ming Tang, Huacheng Luo, Jianrong Lu

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cancer cells exhibit altered epigenome. It is well established that aberrant histone modifications, DNA methylation, and chromatin organization may deregulate oncogenes and tumor suppressors, and contribute significantly to cancer phenotypes. Recent large-scale exome and genome sequencing analyses of thousands of human cancer samples have identified driver mutations in genes encoding chromatin regulatory proteins that directly control chromatin modifications, nucleosome remodeling, and long-range chromatin interactions. These studies reveal a mechanistic link between genetic mutations and epigenetic alterations in cancer, and highlight the genetic basis for perturbed cancer epigenome. This review summarizes the current knowledge on chromatin regulators that are significantly mutated in human cancer, which include MLL1-4, SETD2, NSD1, UTX, SMCX, ARID5B, BAP1, ASXL1, CBP and p300, DNMT3A, TET2, IDH1 and IDH2, the SWI/SNF complex, CHD4, CHD8, CTCF, and the cohesin complex.

Original languageEnglish (US)
Title of host publicationEpigenetic Gene Expression and Regulation
PublisherElsevier Inc.
Pages265-289
Number of pages25
ISBN (Electronic)9780128004715
ISBN (Print)9780127999586
DOIs
StatePublished - Jan 1 2015

Fingerprint

Chromatin
Neoplasms
Histone Code
Exome
Mutation
Nucleosomes
DNA Methylation
Oncogenes
Epigenomics
Genome
Phenotype
Genes
Proteins

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Tang, M., Luo, H., & Lu, J. (2015). Genetically altered cancer epigenome. In Epigenetic Gene Expression and Regulation (pp. 265-289). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-799958-6.00012-3
Tang, Ming ; Luo, Huacheng ; Lu, Jianrong. / Genetically altered cancer epigenome. Epigenetic Gene Expression and Regulation. Elsevier Inc., 2015. pp. 265-289
@inbook{d6daab6a44af4df58b21c5cec8c14ad8,
title = "Genetically altered cancer epigenome",
abstract = "Cancer cells exhibit altered epigenome. It is well established that aberrant histone modifications, DNA methylation, and chromatin organization may deregulate oncogenes and tumor suppressors, and contribute significantly to cancer phenotypes. Recent large-scale exome and genome sequencing analyses of thousands of human cancer samples have identified driver mutations in genes encoding chromatin regulatory proteins that directly control chromatin modifications, nucleosome remodeling, and long-range chromatin interactions. These studies reveal a mechanistic link between genetic mutations and epigenetic alterations in cancer, and highlight the genetic basis for perturbed cancer epigenome. This review summarizes the current knowledge on chromatin regulators that are significantly mutated in human cancer, which include MLL1-4, SETD2, NSD1, UTX, SMCX, ARID5B, BAP1, ASXL1, CBP and p300, DNMT3A, TET2, IDH1 and IDH2, the SWI/SNF complex, CHD4, CHD8, CTCF, and the cohesin complex.",
author = "Ming Tang and Huacheng Luo and Jianrong Lu",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-799958-6.00012-3",
language = "English (US)",
isbn = "9780127999586",
pages = "265--289",
booktitle = "Epigenetic Gene Expression and Regulation",
publisher = "Elsevier Inc.",
address = "United States",

}

Tang, M, Luo, H & Lu, J 2015, Genetically altered cancer epigenome. in Epigenetic Gene Expression and Regulation. Elsevier Inc., pp. 265-289. https://doi.org/10.1016/B978-0-12-799958-6.00012-3

Genetically altered cancer epigenome. / Tang, Ming; Luo, Huacheng; Lu, Jianrong.

Epigenetic Gene Expression and Regulation. Elsevier Inc., 2015. p. 265-289.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Genetically altered cancer epigenome

AU - Tang, Ming

AU - Luo, Huacheng

AU - Lu, Jianrong

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Cancer cells exhibit altered epigenome. It is well established that aberrant histone modifications, DNA methylation, and chromatin organization may deregulate oncogenes and tumor suppressors, and contribute significantly to cancer phenotypes. Recent large-scale exome and genome sequencing analyses of thousands of human cancer samples have identified driver mutations in genes encoding chromatin regulatory proteins that directly control chromatin modifications, nucleosome remodeling, and long-range chromatin interactions. These studies reveal a mechanistic link between genetic mutations and epigenetic alterations in cancer, and highlight the genetic basis for perturbed cancer epigenome. This review summarizes the current knowledge on chromatin regulators that are significantly mutated in human cancer, which include MLL1-4, SETD2, NSD1, UTX, SMCX, ARID5B, BAP1, ASXL1, CBP and p300, DNMT3A, TET2, IDH1 and IDH2, the SWI/SNF complex, CHD4, CHD8, CTCF, and the cohesin complex.

AB - Cancer cells exhibit altered epigenome. It is well established that aberrant histone modifications, DNA methylation, and chromatin organization may deregulate oncogenes and tumor suppressors, and contribute significantly to cancer phenotypes. Recent large-scale exome and genome sequencing analyses of thousands of human cancer samples have identified driver mutations in genes encoding chromatin regulatory proteins that directly control chromatin modifications, nucleosome remodeling, and long-range chromatin interactions. These studies reveal a mechanistic link between genetic mutations and epigenetic alterations in cancer, and highlight the genetic basis for perturbed cancer epigenome. This review summarizes the current knowledge on chromatin regulators that are significantly mutated in human cancer, which include MLL1-4, SETD2, NSD1, UTX, SMCX, ARID5B, BAP1, ASXL1, CBP and p300, DNMT3A, TET2, IDH1 and IDH2, the SWI/SNF complex, CHD4, CHD8, CTCF, and the cohesin complex.

UR - http://www.scopus.com/inward/record.url?scp=85017389211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017389211&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-799958-6.00012-3

DO - 10.1016/B978-0-12-799958-6.00012-3

M3 - Chapter

AN - SCOPUS:85017389211

SN - 9780127999586

SP - 265

EP - 289

BT - Epigenetic Gene Expression and Regulation

PB - Elsevier Inc.

ER -

Tang M, Luo H, Lu J. Genetically altered cancer epigenome. In Epigenetic Gene Expression and Regulation. Elsevier Inc. 2015. p. 265-289 https://doi.org/10.1016/B978-0-12-799958-6.00012-3